Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research brief

Indian Pediatr 2014;51: 637-640

Predictors of Mortality in Neonates with Meconium Aspiration Syndrome


Deepak Louis, Venkataseshan Sundaram, Kanya Mukhopadhyay, Sourabh Dutta and Praveen Kumar

From the Newborn Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Correspondence to: Dr Venkataseshan Sundaram, Assistant Professor, Newborn Unit, Department of Pediatrics, PGIMER, Chandigarh 160 012, India.
Email: [email protected]

Received: January 24, 2014;
Initial review: February 28, 2014;
Accepted: May 12, 2014.

 

Objective: To identify risk factors for mortality in neonates with meconium aspiration syndrome. Methods: All neonates (2004-2010) with meconium aspiration syndrome, irrespective of gestation were included. Risk factors were compared between those who died and survived. Results: Out of 172 included neonates, 44 (26%) died. Mean (SD) gestation and birth weight were 37.9 (2.3) weeks and 2545 (646g), respectively. Myocardial dysfunction [aOR 28.4; 95% CI (8.0-101); P<0.001] and higher initial oxygen requirement [aOR 1.04; 95% CI (1.02-1.07); P<0.001] increased odds of dying while a higher birth weight [aOR 0.998; 95% CI (0.997-1.00); P=0.005] reduced the odds of dying. Conclusions: Meconium aspiration syndrome is associated with significant mortality. Myocardial dysfunction, birth weight, and initial oxygen requirement are independent predictors of mortality.

Keywords: Mortality, Neonate, Outcome, Prognosis, Risk factors.



T
he most important consequence for a neonate born through meconium stained liquor (MSL) is Meconium aspiration syndrome (MAS), that occurs in 1-3% of live births [1,2]. It is an important cause of neonatal morbidity and mortality in otherwise healthy term and post-term infants, with a case fatality rate approaching 40% [3]. Only a few studies from developing countries have looked at the clinical profile of MAS, associated morbidities and predictors of mortality [4-6]. In this study, we aimed to evaluate the morbidity profile of neonates with MAS, and identify the risk factors that predict mortality during hospital stay in such neonates.

Methods

This case-control study was conducted in a level III neonatal unit in Northern India. All inborn babies, irrespective of their gestational age and birth weight, with a diagnosis of MAS – born between January 2004 and December 2010 – were included. MAS was diagnosed when the neonate had respiratory distress in the presence of MSL with onset within first 24 hours of life, and a chest X-ray showed non-homogenous infiltrates with or without hyperinflation.

Babies born through MSL were managed as per NRP guidelines as modified from time to time [7]. Pediatric residents/neonatology trainees attended all deliveries with MSL and performed endotracheal suction if indicated. Babies who had significant respiratory distress were started on non-invasive ventilation, Continuous Positive Airway Pressue (CPAP) or Non-invasive Mechanical Ventilation (NIMV), and mechanically ventilated whenever indicated. Inhaled nitric oxide was available only in the later part of the study period. Case records of the patients were retrieved. Ante-partum and intra-partum risk factors were recorded. Chorio-amnionitis was defined as intra-partum maternal fever of 37.80C with at least two of the four: fetal tachycardia (>180/min), uterine tenderness, maternal leucocyte count >15,000/mm3 and foul smelling vaginal discharge. Risk factors were compared among survivors and those who died.

For the purpose of the study, Persistent pulmonary hypertension of newborn (PPHN) was defined on the basis of labile oxygen saturation, a pre-and post-ductal oxygen saturation difference of >10% or pre-and postductal partial pressure of arterial oxygen (PaO2) difference of >20 mmHg with or without the presence of echocardiographic evidence of PPHN. Diagnosis of PPHN on echocardiogram was based on the peak velocity of a tricuspid regurgitant jet with a peak pulmonary pressure gradient of >20 mmHg [8,9]. Hypotensive shock was defined as presence of low pulse volume, tachycardia, skin mottling and a capillary refill time >3 seconds along with a systolic blood pressure (BP) and/or a diastolic BP <5th centile [10]. A diagnosis of hypoxic ischemic encephalopathy (HIE) was made based on Sarnat and Sarnat staging in babies 36 weeks of gestation and Levene’s staging in babies <36 weeks [11,12]. Myocardial dysfunction was diagnosed on the basis of edema, third space fluid collection, hepatomegaly, S3 gallop or cardiogenic shock, manifesting with capillary filling time (CFT) >3 seconds or low BP along with elevated Creatinine Phosphokinase – Muscle Brain (CPK-MB >75 IU/L). Renal dysfunction was defined as an elevated blood urea (>60 mg/dL) or serum creatinine (>1 mg/dL) in the presence of normal maternal renal function.

Data were entered in to SPSS software version 15 (SPSS Inc., Chicago, IL, USA). Categorical variables were compared using Chi-square test or Fisher Exact test. Numerical variables were tested for normality using the Kolmogorov – Smirnov test. Normally distributed numerical variables were compared using the Student-t test and those with a skewed distribution were compared using the Mann-Whitney U test. A univariate analysis followed by a multivariable logistic regression model (forward, step-wise) was done to identify factors that were significantly associated with mortality. Variables to be entered in the model were chosen primarily based on a biologically plausible association between the predictor and response variable; a correlation matrix was drawn to identify a strong prior relation between the variables; 1 variable was entered in the model for every 10 subjects with the outcome of interest. A ‘P’ value of <0.05 was considered significant. The predictive ability of the model as a whole was calculated both by the conventional manner as well as using the concordance ‘c’ statistic.

Results

One hundred and seventy neonates were diagnosed to have MAS during the study period and 44 (26%) of them died. Sixty (35%) neonates were mechanically ventilated; it was the initial mode in 42 (25%). Non-invasive ventilation was used in 44 (26%) neonates – in 24 (14%) as the primary mode, and in 20 (12%) as a weaning mode. Median age at onset of respiratory distress was 0 hour (IQR, 0 to 1 hour). The median durations of ventilation and oxygen supplementation were was 22 hours and 66 hours, respectively. Four out of 170 (2.3%) patients received surfactant therapy for MAS. The median duration of hospital stay among those who survived was 168 hours and the median time to mortality was 24 hours.

PPHN, hypotensive shock, HIE (all grades) and myocardial dysfunction was observed in 29 (17%), 37 (22%), 79 (46%) and 37 (22%) neonates, respectively. Inhaled nitric oxide was used for PPHN in one patient whereas sildenafil was used in 3 patients. HIE was mild in 25 (32%), moderate in 44 (56%) and severe in 10 (12%) neonates. Myocardial dysfunction manifested as cardiogenic shock in 31 (18%) neonates, tricuspid regurgitation murmur in 1 (0.6%) and only with elevated CPK-MB levels in the remaining 5 (3%). Pneumothorax was detected in 7 neonates (4%) while one baby (0.6%) had pneumomediastinum.

TABLE I Comparison of Risk Factors Between Neonates Who Died vs. Survivors
Risk factor Died (n=44) Survived (n=126) Odds ratio or MD (95% CI) P value
Gestation * (wk) 37.6 (2.5) 37.9 (2.2) 0.3 (-0.45–1.1) 0.45
Preterm (<37 wk) 12 (27) 25 (20) 1.7 (0.8–3.9) 0.17
Birth weight (g)* 2270 (500) 2641 (664) 371 (154–588) 0.001
Low birth weight (<2500g) 29 (67) 48 (38) 3.1 (1.5–6.5) 0.002
Females 24 (55) 45 (36) 2.2 (1.1–4.3) 0.02
Small for gestational age 20 (45) 34 (27) 2.3 (1.1–4.6) 0.02
Thick MSL (n=168) 36 (82) 98 (78) 1.2 (0.5–2.9) 0.6
Caesarean section 25 (57) 64 (51) 1.3 (0.6–2.5) 0.49
Non-vigorous at birth 39 (88) 87 (69) 3.5 (1.3–9.5) 0.01
Cord pH* 7.02 (0.2) 7.15 (0.1) 0.13 (0.05–0.2) 0.001
Apgar score at 1 min# 3 (1, 5) 5 (3, 7) 1.9 (1.1–2.7) <0.001
Apgar score at 5 min# 6 (3, 8) 8 (7, 9) 1.9 (1.2–2.5) <0.001
Age of onset of resp. distress (h) # 0 (0, 0) 0 (0, 1) 0.9 (-0.6–2.4) 0.23
Need for mechanical ventilation 33 (75) 27 (21) 11 (4.9–24.6) <0.001
Initial oxygen requirement * (%) 88 (19) 57 (23) -31.1 (-39– -23) <0.001
Maximum oxygen requirement * (%) 95 (14) 62 (24) -32.6 (-4– -24) <0.001
Duration of ventilation (h)# 17 (10, 38) 52 (24, 84) 0.9 (-17.7 – 19.6) 0.92
Duration of oxygen supplementation (h)# 25 (10, 53) 72 (36, 120) 72.2 (19.0–125.4) 0.008
Initial PaO2 (mm Hg)# 50 (43, 83) 60 (48, 104) 15.3 (-7.2 – 37.8) 0.18
Persistent pulmonary hypertension 17(39) 12 (10) 7.6 (3.2–18.3) <0.001
Air leak 4 (9) 4 (3) 3.1 (0.7–12.8) 0.13
Hypotensive shock 30 (68) 7 (6) 36.4 (13.5–98.2) <0.001
Hypoxic ischemic encephalopathy 33 (75) 46 (37) 5.2 (2.4–11.3) <0.001
Seizure 11 (25) 15 (12) 2.5 (1.0–5.9) 0.04
Myocardial dysfunction 29 (66) 8 (6) 31.6 (12.1–82.2) <0.001
Renal dysfunction 9 (20) 8 (6) 3.9 (1.4–10.9) 0.006
MSL: meconium stained liquor; MD: mean difference; Values of *mean (SD); #median (IQR); rest all expressed as n (%).

Risk factors of mortality are presented in Table I. Of the 18 putative risk factors that emerged significant in univariate analysis, 5 factors namely birth weight (in grams unit), Apgar score at 5 minute (in a scale of 1 to 10), initial oxygen requirement (FiO2 in % unit), and need for mechanical ventilation, and myocardial dysfunction were entered into the regression model. Myocardial dysfunction was chosen over presence of shock as both these variables had a high degree of correlation between them on a correlation matrix and based on a biological assumption that myocardial dysfunction would have preceded shock. The prediction model identified that presence of myocardial dysfunction and a higher initial oxygen requirement increased the odds of death whereas a higher birth weight reduced the odds of death in these neonates with every 1% increase in initial O2 requirement increasing the odds of death by 4.4% in comparison to baseline. We also observed that for every 100 grams increase in birth weight, the odds of death decreased by 20% from the baseline risk (Table II). This model as a whole had a sensitivity of 78%, specificity of 94%, positive predictive value of 83%, negative predictive value of 93%, a positive likelihood ratio of 13 and a negative likelihood ratio of 0.2. The concordance statistic (c-statistic) of the model was 0.95 (95% CI 91.6-98.9; P<0.001).

TABLE II Multivariate Logistic Regression Model for Predicting Death in Neonates With Meconium Aspiration Syndrome
Variables β coefficient Adjusted Odds ratio (95% CI) P value
Birth weight (g) - 0.002 0.998 (0.997-1.00) 0.005
Initial oxygen requirement (%) 0.044 1.044 (1.02-1.07) <0.001
Myocardial dysfunction 3.35 28.5 (8.0-101) <0.001
Note: For binomial independent variable (Myocardial dysfunction) – 0 (no event) was taken as reference category; direction of the β coefficient indicates the direction of the association

Discussion

In this study on 170 neonates who developed MAS, one-fourth died. About half of the neonates had HIE whereas a significant number of neonates developed complications. Presence of myocardial dysfunction and a higher initial oxygen requirement independently increased the odds of mortality.

Previous studies have shown a wide range (5-40%) in the mortality among infants with MAS with recent studies showing lower (<15%) mortality rate [13-15]. A higher mortality rate observed in the current study could be related to higher proportion of small for gestational age (SGA) neonates. An association between intra-uterine growth retardation (IUGR) and MAS has been described earlier [5]. The emergence of myocardial dysfunction as an independent risk factor for death indicates the major role of cardiovascular instability in modifying the outcome in such neonates. This also emphasizes the need for aggressive and close cardiovascular monitoring and early vascular support in such neonates. Previous studies have observed PPHN, pneumothorax, birth asphyxia, need for respiratory support in the first 48 hours of life and the need for vasopressor support as independent predictors of mortality [5,15,16].

Our study has few limitations. First, PPHN and myocardial dysfunction were diagnosed primarily on the basis of clinical presentation, and were not always confirmed by echocardiography. Second, MAS associated mortality (cause-specific) could not be separated out of all-cause mortality due to the presence of various co-morbidities, especially HIE.

To conclude, MAS is associated with significant mortality during the hospital stay. Myocardial dysfunction and a higher initial oxygen requirement increased the odds of death whereas a higher birth weight decreases the odds of death.

Contributors: DL: Data collection and drafted the manuscript; VS: designed the study, performed the analysis, helped in drafting, and reviewed the manuscript; KM, SD and PK: supervised the study and critically reviewed the manuscript.

Funding: None; Competing interests: None stated.


What This Study Adds?

• Meconium aspiration syndrome in neonates is associated with high (26%) mortality.

• Myocardial dysfunction and higher initial oxygen requirement is associated with higher mortality whereas a higher birth weight is associated with decreased mortality.

References

1. Ross MG. Meconium aspiration syndrome – more than intrapartum meconium. N Engl J Med. 2005;353:946-8

2. Locatelli A, Regalia AL, Patregnani C, Ratti M, Toso L, Ghidini A. Prognostic value of change in amniotic fluid color during labor. Fetal Diagn Ther. 2005;20:5-9

3. Qian L, Liu C, Zhuang W, Guo Y, Yu J, Chen H, et al. Neonatal respiratory failure: a 12-month clinical epidemio-logic study from 2004 to 2005 in China. Pediatrics. 2008;121:e1115-24

4. Malik AS, Hillman D. Meconium aspiration syndrome and neonatal outcome in a developing country. Ann Trop Pediatr. 1994;14:47-51

5. Gupta V, Bhatia BD, Mishra OP. Meconium stained amniotic fluid: antenatal, intrapartum and neonatal attributes. Indian Pediatr. 1996;33:293-7

6. Bhat RY, Rao A. Meconium-stained amniotic fluid and meconium aspiration syndrome: a prospective study. Ann Trop Pediatr. 2008;28:199-203

7. Kattwinkel J, Perlman JM, Aziz K, Colby C, Fairchild K, Gallagher J, et al. Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2010;126:e1400-13.

8. Konduri GG. New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol. 2004;31:591-611.

9. Walsh MC, Stork EK. Persistent pulmonary hypertension of the newborn. Rational therapy based on patho-physiology. Clin Perinatol. 2001;28:609-27.

10. Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol. 1995;15:470-9.

11. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696-705.

12. Levene ML, Kornberg J, Williams TH. The incidence and severity of post-asphyxial encephalopathy in full-term infants. Early Hum Dev. 1985;11:21-6.

13. Sriram S, Wall SN, Khoshnood B, Singh JK, Hsieh HL, Lee KS. Racial disparity in meconium-stained amniotic fluid and meconium aspiration syndrome in the United States, 1989-2000. Obstet Gynecol. 2003;102:1262-8.

14. Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we made a difference? Pediatrics. 1990;85:715-21.

15. Yoder BA, Kirsch EA, Barth WH, Gordon MC. Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol. 2002;99:731-9

16. Singh BS, Clark RH, Powers RJ, Spitzer AR. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during a ten-year period. J Perinatol. 2009;29:497-503.

 

Copyright © 1999-2014  Indian Pediatrics